| 1 |
Lecoq L, Wang S, Dujardin M, Zimmermann P, Schuster L, Fogeron ML, Briday M, Schledorn M, Wiegand T, Cole L, Montserret R, Bressanelli S, Meier BH, Nassal M, Böckmann A. A pocket-factor-triggered conformational switch in the hepatitis B virus capsid. Proc Natl Acad Sci U S A 2021;118:e2022464118. [PMID: 33879615 DOI: 10.1073/pnas.2022464118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 2 |
Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. The evolution and clinical impact of hepatitis B virus genome diversity. Nat Rev Gastroenterol Hepatol 2020;17:618-34. [PMID: 32467580 DOI: 10.1038/s41575-020-0296-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 3 |
Ruan J, Ping CY, Sun S, Cheng X, Han PY, Zhang YG, Sun DX. Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines. World J Gastroenterol 2019; 25(39): 5961-5972 [PMID: 31660033 DOI: 10.3748/wjg.v25.i39.5961] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 4 |
Heger-Stevic J, Zimmermann P, Lecoq L, Böttcher B, Nassal M. Hepatitis B virus core protein phosphorylation: Identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure. PLoS Pathog 2018;14:e1007488. [PMID: 30566530 DOI: 10.1371/journal.ppat.1007488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 5 |
Budzinska MA, Shackel NA, Urban S, Tu T. Cellular Genomic Sites of Hepatitis B Virus DNA Integration. Genes (Basel) 2018;9:E365. [PMID: 30037029 DOI: 10.3390/genes9070365] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 6 |
Schreiner S, Nassal M. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond? Viruses 2017;9:E125. [PMID: 28531167 DOI: 10.3390/v9050125] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 7 |
Tu T, Budzinska MA, Shackel NA, Urban S. HBV DNA Integration: Molecular Mechanisms and Clinical Implications. Viruses. 2017;9. [PMID: 28394272 DOI: 10.3390/v9040075] [Cited by in Crossref: 200] [Cited by in F6Publishing: 210] [Article Influence: 33.3] [Reference Citation Analysis]
|
| 8 |
Huang H, Zhou W, Zhu H, Zhou P, Shi X. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Toxicol Appl Pharmacol 2017;323:36-43. [PMID: 28322895 DOI: 10.1016/j.taap.2017.03.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
|
